Management of central serous chorioretinopathy by Jalaukavcharana- a case study

Authors

  • Nisar Ali Khan
  • Kalpana S. Wakode
  • Komal Anil Haran

DOI:

https://doi.org/10.70066/jahm.v11i4.759

Keywords:

Central serous chorioretinopathy (CSCR), Dhoomdarshi, 3rd Patalgata Roga, Jalaukavcharana, Drishtigata Roga.

Abstract

Central serous chorioretinopathy is an idiopathic disorder characterized by local serous detachment of sensory retina at the macula secondary to leakage from the chorio-capillaries, one of most hyperpermeable RPE sites. Though the disease is self-limiting but due to recurrence and severity it may lead to permanent vision loss. In Ayurveda pathogenesis, sign and symptoms of CSCR have similarities with Dhoomdarshi and 3rd patalgata roga which described under Drishtigata Roga in all classic of Ayurveda. Rakta-mokshana (Leech Therapy) by Jalauka (Leech) application is done and after the treatment the quality of vision has shown significant improvement. Foveal thickness and macular volume in OCT findings also showed significant Reduction.

Author Biographies

Nisar Ali Khan

Associate Professor and HOD, Dept. of Shalakyatantra, Government Ayurved College, Nanded, INDIA

Kalpana S. Wakode

Associate Professor, Dept. of Shalakyatantra, Government Ayurved College, Nanded, INDIA

Komal Anil Haran

PG Scholar 3rd Year, Government Ayurved College, Nanded

Additional Files

Published

2023-05-18

How to Cite

Khan, N. A., Wakode, K. S., & Haran, K. A. . (2023). Management of central serous chorioretinopathy by Jalaukavcharana- a case study. Journal of Ayurveda and Holistic Medicine (JAHM), 11(4). https://doi.org/10.70066/jahm.v11i4.759

Issue

Vol. 11 No. 4 (2023): Journal of Ayurveda and Holistic Medicine (JAHM)

Section

Case Report

License

Copyright (c) 2023 Dr.Komal Anil Haran

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Authors retain the copyright of their work and grant the Journal of Ayurveda and Holistic Medicine (JAHM) the right of first publication. All published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits non-commercial sharing, use, distribution, and adaptation with proper attribution and the same license terms.

JAHM ensures free, irrevocable, worldwide access to its content. Users may copy, distribute, display, and share published works for non-commercial purposes with appropriate credit to the author(s) and the journal. Limited printed copies for personal, non-commercial use are allowed under the same license.

If a submission is not accepted for publication, the author(s) will be notified.

By submitting, authors confirm that the work is original, that all listed authors have contributed and approved it, and that it does not infringe any third-party rights or duplicate work submitted elsewhere.